Goat Anti-Rabbit IgG H&L preadsorbed (ab7085)
Key features and details
- Goat Anti-Rabbit IgG H&L preadsorbed
- Host species: Goat
- Suitable for: ICC/IF, WB, IHC-P, IP, Immunodiffusion, Conjugation, IHC-Fr, ELISA
Related conjugates and formulations
Overview
-
Product name
Goat Anti-Rabbit IgG H&L preadsorbed
See all IgG secondary antibodies -
Host species
Goat -
Target species
Rabbit -
Tested applications
Suitable for: ICC/IF, WB, IHC-P, IP, Immunodiffusion, Conjugation, IHC-Fr, ELISAmore details -
Minimal
cross-reactivity
Chicken, Cow, Goat, Guinea pig, Hamster, Horse, Human, Mouse, Rat, Sheep more details -
Immunogen
Full length native Rabbit IgG (purified).
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
Storage buffer
Preservative: 0.01% Sodium azide
Constituents: 0.424% Potassium phosphate, 0.87% Sodium chloride -
Concentration information loading...
-
Purity
Affinity purified -
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Rabbit IgG coupled to agarose beads. -
Clonality
Polyclonal -
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab7085 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ICC/IF |
1/500 - 1/2000.
|
|
WB |
1/500 - 1/2000.
|
|
IHC-P |
Use at an assay dependent concentration.
|
|
IP |
Use at an assay dependent concentration.
|
|
Immunodiffusion |
Use at an assay dependent concentration.
|
|
Conjugation |
Use at an assay dependent concentration.
|
|
IHC-Fr |
Use at an assay dependent concentration.
|
|
ELISA |
1/270000.
|
Notes |
---|
ICC/IF
1/500 - 1/2000. |
WB
1/500 - 1/2000. |
IHC-P
Use at an assay dependent concentration. |
IP
Use at an assay dependent concentration. |
Immunodiffusion
Use at an assay dependent concentration. |
Conjugation
Use at an assay dependent concentration. |
IHC-Fr
Use at an assay dependent concentration. |
ELISA
1/270000. |
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (3)
ab7085 has been referenced in 3 publications.
- B S A S S et al. Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge. RSC Adv 12:31711-31728 (2022). PubMed: 36380932
- Wang X et al. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop. Oncol Rep 40:241-251 (2018). PubMed: 29749472
- Xiong Y et al. STAT3-regulated long non-coding RNAs lnc-7SK and lnc-IGF2-AS promote hepatitis C virus replication. Mol Med Rep 12:6738-44 (2015). PubMed: 26328522